Home › Companies › Cardiff Oncology, Inc. › 2025-2026
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Cardiff Oncology, Inc.’s Form 8-K, filed June 11, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 11, 2026: 9 items on Cardiff Oncology, Inc.’s Form 8-K, filed June 11, 2026: 6 elected · 3 approved.
Significant dissent: 1 equity or compensation plan (42.9% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore Cardiff Oncology, Inc. in the interactive database Compare manager voting policies
These tallies are Cardiff Oncology, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 11, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Dr. James O. Armitage | 18,806,657 | 0 | 522,756 | -- | 22,285,435 | 100% | Elected | — |
| Elect Director: Dr. Rodney Markin | 18,647,050 | 0 | 682,361 | -- | 22,285,437 | 100% | Elected | — |
| Elect Director: Mani Mohindru, Ph.D. | 18,942,979 | 0 | 386,435 | -- | 22,285,434 | 100% | Elected | — |
| Elect Director: Gary W. Pace, Ph.D. | 18,877,743 | 0 | 451,668 | -- | 22,285,437 | 100% | Elected | — |
| Elect Director: Renee P. Tannenbaum, Pharm.D. | 18,790,068 | 0 | 539,345 | -- | 22,285,435 | 100% | Elected | — |
| Elect Director: Lâle White | 18,710,040 | 0 | 619,373 | -- | 22,285,435 | 100% | Elected | — |
| 2. Appointment of BDO USA, P.C. as the Company's independent registered public accounting firm for its fiscal year ended December 31, 2026 | 40,239,508 | 1,070,807 | 304,529 | -- | 4 | 97% | Approved | — |
| 3. An amendment to the Company's 2021 Equity Incentive Plan to increase the number of shares issuable thereunder to 15,150,000 shares | 10,740,460 | 8,063,520 | 525,431 | -- | 22,285,437 | 57% | Approved | — |
| 4. Advisory vote on the compensation of the Company's named executive officers | 17,120,176 | 1,772,185 | 437,049 | -- | 22,285,438 | 91% | Approved | — |
Source: Cardiff Oncology, Inc., Form 8-K, filed with the SEC on June 11, 2026 — read the filing on EDGAR.
See voting trends for Health Care companies, 2025-2026: shareholder support by sector and by company size.
109 asset managers disclosed a vote on at least one Cardiff Oncology, Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
100% Majority: yes · of votes cast
Prior year: 100.0% for (June 26, 2025 meeting) unchanged
Description as filed by funds: Election of Directors Nominees: Dr. James O. Armitage
Cardiff Oncology, Inc.’s own tally for this item (“Elect Director: Dr. James O. Armitage”): 18,806,657 for, 0 against, per its Form 8-K filed June 11, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “All of the six (6) nominees for director were elected to serve until the 2027 Annual Meeting of Stockholders or until their respective successors have been duly elected and qualified, or until such director's earlier resignation, removal or death.”
Support: 100% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 32 asset managers below reported 844,159 for, 5,678 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| FRANKLIN STRATEGIC SERIES | 438,961 | 0 | 0 | 0 | For |
| Vanguard | 107,443 | 0 | 0 | 0 | For |
| BlackRock | 89,494 | 0 | 0 | 0 | For |
| Lincoln Financial | 44,100 | 0 | 0 | 0 | For |
| Equitable | 43,233 | 0 | 0 | 0 | For |
| Fidelity | 37,721 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 23,084 | 0 | 0 | 0 | For |
| Charles Schwab | 9,534 | 0 | 0 | 0 | For |
| SEI | 7,300 | 0 | 0 | 0 | For |
| Global X | 6,840 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,767 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 0 | 5,678 | Withhold |
| Venerable Variable Insurance Trust | 5,135 | 0 | 0 | 0 | For |
| Principal | 4,557 | 0 | 0 | 0 | For |
| ProShares | 3,636 | 0 | 0 | 0 | For |
| Goldman Sachs | 2,752 | 0 | 0 | 0 | For |
| Nationwide | 2,553 | 0 | 0 | 0 | For |
| State Street | 2,430 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 1,600 | 0 | 0 | 0 | For |
| TIAA | 1,564 | 0 | 0 | 0 | For |
| Morgan Stanley | 1,563 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 1,300 | 0 | 0 | 0 | For |
| Voya | 806 | 0 | 0 | 0 | For |
| John Hancock | 589 | 0 | 0 | 0 | For |
| Guggenheim | 565 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. All 32 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
100% Majority: yes · of votes cast
Prior year: 100.0% for (June 26, 2025 meeting) unchanged
Description as filed by funds: Election of Directors Nominees: Dr. Rodney Markin
Cardiff Oncology, Inc.’s own tally for this item (“Elect Director: Dr. Rodney Markin”): 18,647,050 for, 0 against, per its Form 8-K filed June 11, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “All of the six (6) nominees for director were elected to serve until the 2027 Annual Meeting of Stockholders or until their respective successors have been duly elected and qualified, or until such director's earlier resignation, removal or death.”
Support: 100% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 32 asset managers below reported 843,530 for, 6,308 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| FRANKLIN STRATEGIC SERIES | 438,961 | 0 | 0 | 0 | For |
| Vanguard | 106,814 | 0 | 0 | 630 | For |
| BlackRock | 89,494 | 0 | 0 | 0 | For |
| Lincoln Financial | 44,100 | 0 | 0 | 0 | For |
| Equitable | 43,233 | 0 | 0 | 0 | For |
| Fidelity | 37,721 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 23,084 | 0 | 0 | 0 | For |
| Charles Schwab | 9,534 | 0 | 0 | 0 | For |
| SEI | 7,300 | 0 | 0 | 0 | For |
| Global X | 6,840 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,767 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 0 | 5,678 | Withhold |
| Venerable Variable Insurance Trust | 5,135 | 0 | 0 | 0 | For |
| Principal | 4,557 | 0 | 0 | 0 | For |
| ProShares | 3,636 | 0 | 0 | 0 | For |
| Goldman Sachs | 2,752 | 0 | 0 | 0 | For |
| Nationwide | 2,553 | 0 | 0 | 0 | For |
| State Street | 2,430 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 1,600 | 0 | 0 | 0 | For |
| TIAA | 1,564 | 0 | 0 | 0 | For |
| Morgan Stanley | 1,563 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 1,300 | 0 | 0 | 0 | For |
| Voya | 806 | 0 | 0 | 0 | For |
| John Hancock | 589 | 0 | 0 | 0 | For |
| Guggenheim | 565 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. All 32 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
100% Majority: yes · of votes cast
Prior year: 100.0% for (June 26, 2025 meeting) unchanged
Description as filed by funds: Election of Directors Nominees: Gary W. Pace, Ph.D.
Cardiff Oncology, Inc.’s own tally for this item (“Elect Director: Gary W. Pace, Ph.D.”): 18,877,743 for, 0 against, per its Form 8-K filed June 11, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “All of the six (6) nominees for director were elected to serve until the 2027 Annual Meeting of Stockholders or until their respective successors have been duly elected and qualified, or until such director's earlier resignation, removal or death.”
Support: 100% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 32 asset managers below reported 843,953 for, 5,884 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| FRANKLIN STRATEGIC SERIES | 438,961 | 0 | 0 | 0 | For |
| Vanguard | 107,237 | 0 | 0 | 206 | For |
| BlackRock | 89,494 | 0 | 0 | 0 | For |
| Lincoln Financial | 44,100 | 0 | 0 | 0 | For |
| Equitable | 43,233 | 0 | 0 | 0 | For |
| Fidelity | 37,721 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 23,084 | 0 | 0 | 0 | For |
| Charles Schwab | 9,534 | 0 | 0 | 0 | For |
| SEI | 7,300 | 0 | 0 | 0 | For |
| Global X | 6,840 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,767 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 0 | 5,678 | Withhold |
| Venerable Variable Insurance Trust | 5,135 | 0 | 0 | 0 | For |
| Principal | 4,557 | 0 | 0 | 0 | For |
| ProShares | 3,636 | 0 | 0 | 0 | For |
| Goldman Sachs | 2,752 | 0 | 0 | 0 | For |
| Nationwide | 2,553 | 0 | 0 | 0 | For |
| State Street | 2,430 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 1,600 | 0 | 0 | 0 | For |
| TIAA | 1,564 | 0 | 0 | 0 | For |
| Morgan Stanley | 1,563 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 1,300 | 0 | 0 | 0 | For |
| Voya | 806 | 0 | 0 | 0 | For |
| John Hancock | 589 | 0 | 0 | 0 | For |
| Guggenheim | 565 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. All 32 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
100% Majority: yes · of votes cast
Prior year: 100.0% for (June 26, 2025 meeting) unchanged
Description as filed by funds: Election of Directors Nominees: Lale White
Cardiff Oncology, Inc.’s own tally for this item (“Elect Director: Lâle White”): 18,710,040 for, 0 against, per its Form 8-K filed June 11, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “All of the six (6) nominees for director were elected to serve until the 2027 Annual Meeting of Stockholders or until their respective successors have been duly elected and qualified, or until such director's earlier resignation, removal or death.”
Support: 100% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 32 asset managers below reported 849,837 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| FRANKLIN STRATEGIC SERIES | 438,961 | 0 | 0 | 0 | For |
| Vanguard | 107,443 | 0 | 0 | 0 | For |
| BlackRock | 89,494 | 0 | 0 | 0 | For |
| Lincoln Financial | 44,100 | 0 | 0 | 0 | For |
| Equitable | 43,233 | 0 | 0 | 0 | For |
| Fidelity | 37,721 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 23,084 | 0 | 0 | 0 | For |
| Charles Schwab | 9,534 | 0 | 0 | 0 | For |
| SEI | 7,300 | 0 | 0 | 0 | For |
| Global X | 6,840 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,767 | 0 | 0 | 0 | For |
| Calvert | 5,678 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 5,135 | 0 | 0 | 0 | For |
| Principal | 4,557 | 0 | 0 | 0 | For |
| ProShares | 3,636 | 0 | 0 | 0 | For |
| Goldman Sachs | 2,752 | 0 | 0 | 0 | For |
| Nationwide | 2,553 | 0 | 0 | 0 | For |
| State Street | 2,430 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 1,600 | 0 | 0 | 0 | For |
| TIAA | 1,564 | 0 | 0 | 0 | For |
| Morgan Stanley | 1,563 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 1,300 | 0 | 0 | 0 | For |
| Voya | 806 | 0 | 0 | 0 | For |
| John Hancock | 589 | 0 | 0 | 0 | For |
| Guggenheim | 565 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. All 32 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
100% Majority: yes · of votes cast
Prior year: 100.0% for (June 26, 2025 meeting) unchanged
Description as filed by funds: Election of Directors Nominees: Mani Mohindru, Ph.D.
Cardiff Oncology, Inc.’s own tally for this item (“Elect Director: Mani Mohindru, Ph.D.”): 18,942,979 for, 0 against, per its Form 8-K filed June 11, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “All of the six (6) nominees for director were elected to serve until the 2027 Annual Meeting of Stockholders or until their respective successors have been duly elected and qualified, or until such director's earlier resignation, removal or death.”
Support: 100% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 32 asset managers below reported 849,414 for, 424 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| FRANKLIN STRATEGIC SERIES | 438,961 | 0 | 0 | 0 | For |
| Vanguard | 107,020 | 0 | 0 | 424 | For |
| BlackRock | 89,494 | 0 | 0 | 0 | For |
| Lincoln Financial | 44,100 | 0 | 0 | 0 | For |
| Equitable | 43,233 | 0 | 0 | 0 | For |
| Fidelity | 37,721 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 23,084 | 0 | 0 | 0 | For |
| Charles Schwab | 9,534 | 0 | 0 | 0 | For |
| SEI | 7,300 | 0 | 0 | 0 | For |
| Global X | 6,840 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,767 | 0 | 0 | 0 | For |
| Calvert | 5,678 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 5,135 | 0 | 0 | 0 | For |
| Principal | 4,557 | 0 | 0 | 0 | For |
| ProShares | 3,636 | 0 | 0 | 0 | For |
| Goldman Sachs | 2,752 | 0 | 0 | 0 | For |
| Nationwide | 2,553 | 0 | 0 | 0 | For |
| State Street | 2,430 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 1,600 | 0 | 0 | 0 | For |
| TIAA | 1,564 | 0 | 0 | 0 | For |
| Morgan Stanley | 1,563 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 1,300 | 0 | 0 | 0 | For |
| Voya | 806 | 0 | 0 | 0 | For |
| John Hancock | 589 | 0 | 0 | 0 | For |
| Guggenheim | 565 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. All 32 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
100% Majority: yes · of votes cast
Prior year: 100.0% for (June 26, 2025 meeting) unchanged
Description as filed by funds: Election of Directors Nominees: Renee P. Tannenbaum, Pharm.D.
Cardiff Oncology, Inc.’s own tally for this item (“Elect Director: Renee P. Tannenbaum, Pharm.D.”): 18,790,068 for, 0 against, per its Form 8-K filed June 11, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “All of the six (6) nominees for director were elected to serve until the 2027 Annual Meeting of Stockholders or until their respective successors have been duly elected and qualified, or until such director's earlier resignation, removal or death.”
Support: 100% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 32 asset managers below reported 843,736 for, 6,102 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| FRANKLIN STRATEGIC SERIES | 438,961 | 0 | 0 | 0 | For |
| Vanguard | 107,020 | 0 | 0 | 424 | For |
| BlackRock | 89,494 | 0 | 0 | 0 | For |
| Lincoln Financial | 44,100 | 0 | 0 | 0 | For |
| Equitable | 43,233 | 0 | 0 | 0 | For |
| Fidelity | 37,721 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 23,084 | 0 | 0 | 0 | For |
| Charles Schwab | 9,534 | 0 | 0 | 0 | For |
| SEI | 7,300 | 0 | 0 | 0 | For |
| Global X | 6,840 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,767 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 0 | 5,678 | Withhold |
| Venerable Variable Insurance Trust | 5,135 | 0 | 0 | 0 | For |
| Principal | 4,557 | 0 | 0 | 0 | For |
| ProShares | 3,636 | 0 | 0 | 0 | For |
| Goldman Sachs | 2,752 | 0 | 0 | 0 | For |
| Nationwide | 2,553 | 0 | 0 | 0 | For |
| State Street | 2,430 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 1,600 | 0 | 0 | 0 | For |
| TIAA | 1,564 | 0 | 0 | 0 | For |
| Morgan Stanley | 1,563 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 1,300 | 0 | 0 | 0 | For |
| Voya | 806 | 0 | 0 | 0 | For |
| John Hancock | 589 | 0 | 0 | 0 | For |
| Guggenheim | 565 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. All 32 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
57% Approved · of votes cast
Prior year: 77.3% for (June 26, 2025 meeting) ▼ 20.1 pts
Description as filed by funds: Proposal to approve an amendment to the Company's 2021 Omnibus Equity Incentive Plan to increase the number of shares issuable thereunder to 15,150,000 shares from 12,150,000 shares.
Cardiff Oncology, Inc.’s own tally for this item (“3. An amendment to the Company's 2021 Equity Incentive Plan to increase the number of shares issuable thereunder to 15,150,000 shares”): 10,740,460 for, 8,063,520 against — passed, per its Form 8-K filed June 11, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “An amendment to the Company's 2021 Equity Incentive Plan to increase the number of shares issuable thereunder to 15,150,000 shares was approved by the stockholders by the votes set forth in the table below:”
Support: 57% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 33 asset managers below reported 305,058 for, 546,779 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| FRANKLIN STRATEGIC SERIES | 0 | 438,961 | 0 | 0 | Against |
| Vanguard | 107,016 | 427 | 0 | 0 | For |
| BlackRock | 89,494 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 44,100 | 0 | 0 | Against |
| Equitable | 13,053 | 30,180 | 0 | 0 | Mixed |
| Fidelity | 34,539 | 3,182 | 0 | 0 | Mixed |
| Bridge Builder Trust | 23,084 | 0 | 0 | 0 | For |
| Charles Schwab | 9,534 | 0 | 0 | 0 | For |
| SEI | 7,300 | 0 | 0 | 0 | For |
| Global X | 6,840 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 6,767 | 0 | 0 | Against |
| Calvert | 0 | 5,678 | 0 | 0 | Against |
| Venerable Variable Insurance Trust | 5,135 | 0 | 0 | 0 | For |
| Principal | 0 | 4,557 | 0 | 0 | Against |
| ProShares | 0 | 3,636 | 0 | 0 | Against |
| Goldman Sachs | 2,752 | 0 | 0 | 0 | For |
| Nationwide | 2,553 | 0 | 0 | 0 | For |
| State Street | 0 | 2,430 | 0 | 0 | Against |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Ma | 2,000 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 0 | 1,600 | 0 | 0 | Against |
| TIAA | 1,564 | 0 | 0 | 0 | For |
| Morgan Stanley | 0 | 1,563 | 0 | 0 | Against |
| Blackstone Alternative Investment Funds | 0 | 1,300 | 0 | 0 | Against |
| Voya | 0 | 806 | 0 | 0 | Against |
| John Hancock | 0 | 589 | 0 | 0 | Against |
Showing the 25 largest of 33 asset managers. All 33 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
91% Approved · of votes cast
Prior year: 88.0% for (June 26, 2025 meeting) ▲ 2.6 pts
Description as filed by funds: Proposal to approve, on an advisory basis, the compensation of the Company's named executive officers.
Cardiff Oncology, Inc.’s own tally for this item (“4. Advisory vote on the compensation of the Company's named executive officers”): 17,120,176 for, 1,772,185 against — passed, per its Form 8-K filed June 11, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The advisory vote on the compensation of the Company's named executive officers was approved by the stockholders by the votes set forth in the table below:”
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| FRANKLIN STRATEGIC SERIES | 438,961 | 0 | 0 | 0 | For |
| Vanguard | 107,442 | 1 | 0 | 0 | For |
| BlackRock | 89,494 | 0 | 0 | 0 | For |
| Lincoln Financial | 44,100 | 0 | 0 | 0 | For |
| Equitable | 43,233 | 0 | 0 | 0 | For |
| Fidelity | 37,721 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 23,084 | 0 | 0 | 0 | For |
| Charles Schwab | 9,534 | 0 | 0 | 0 | For |
| SEI | 7,300 | 0 | 0 | 0 | For |
| Global X | 6,840 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,767 | 0 | 0 | 0 | For |
| Calvert | 5,678 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 5,135 | 0 | 0 | 0 | For |
| Principal | 4,557 | 0 | 0 | 0 | For |
| ProShares | 3,636 | 0 | 0 | 0 | For |
| Goldman Sachs | 2,752 | 0 | 0 | 0 | For |
| Nationwide | 2,553 | 0 | 0 | 0 | For |
| State Street | 2,430 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 1,600 | 0 | 0 | 0 | For |
| TIAA | 1,564 | 0 | 0 | 0 | For |
| Morgan Stanley | 1,563 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 1,300 | 0 | 0 | 0 | For |
| Voya | 806 | 0 | 0 | 0 | For |
| John Hancock | 589 | 0 | 0 | 0 | For |
| Guggenheim | 565 | 0 | 0 | 0 | For |
Fund voting reports, all 32 managers: 849,699 for, 138 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Laurion Capital Management LP | 2,628,583 | 0 | 0 | 0 | For |
| PFIZER INC | 2,411,575 | 0 | 0 | 0 | For |
| ACORN CAPITAL ADVISORS, LLC | 1,062,084 | 0 | 0 | 0 | For |
| BLAIR WILLIAM & CO/IL | 717,028 | 0 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 647,703 | 0 | 0 | 0 | For |
| Putnam | 434,407 | 0 | 0 | 0 | For |
| State Street | 402,138 | 1,683 | 0 | 0 | For |
| BlackRock | 323,401 | 50 | 0 | 0 | For |
| Northern Trust | 251,715 | 2,050 | 0 | 0 | For |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 136,390 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 108,956 | 0 | 0 | 0 | For |
| ROCKEFELLER FINANCIAL LLC | 56,500 | 0 | 0 | 0 | For |
| Nuveen | 56,249 | 0 | 0 | 0 | For |
| CAPSTONE INVESTMENT ADVISORS, LLC | 51,190 | 0 | 0 | 0 | For |
| AllianceBernstein | 48,730 | 0 | 0 | 0 | For |
| Glenview Trust Co | 43,128 | 0 | 0 | 0 | For |
| Two Sigma | 39,547 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 38,088 | 0 | 0 | 0 | For |
| JPMorgan | 25,506 | 0 | 0 | 0 | For |
| Baker Ellis Asset Management LLC | 20,000 | 0 | 0 | 0 | For |
| Invesco | 18,956 | 0 | 0 | 0 | For |
| Russell Investments | 17,661 | 0 | 0 | 0 | For |
| Goldman Sachs | 15,539 | 0 | 0 | 0 | For |
| WELLS FARGO CLEARING SERVICES, LLC | 15,125 | 0 | 0 | 0 | For |
| HighTower Advisors, LLC | 15,026 | 0 | 0 | 0 | For |
Institutional-manager reports, all 88 managers: 9,797,306 for, 8,301 against. Showing the 25 largest; every one is in the interactive database (link above).
97% Approved · of votes cast
Description as filed by funds: Proposal to ratify the appointment of BDO USA, P.C. as the Company's independent registered public accountants for fiscal year ending December 31, 2026.
Cardiff Oncology, Inc.’s own tally for this item (“2. Appointment of BDO USA, P.C. as the Company's independent registered public accounting firm for its fiscal year ended December 31, 2026”): 40,239,508 for, 1,070,807 against — passed, per its Form 8-K filed June 11, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The appointment of BDO USA, P.C. as the Company's independent registered public accounting firm for its fiscal year ended December 31, 2026 was ratified and approved by the stockholders by the votes set forth in the table below:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 32 asset managers below reported 849,837 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| FRANKLIN STRATEGIC SERIES | 438,961 | 0 | 0 | 0 | For |
| Vanguard | 107,443 | 0 | 0 | 0 | For |
| BlackRock | 89,494 | 0 | 0 | 0 | For |
| Lincoln Financial | 44,100 | 0 | 0 | 0 | For |
| Equitable | 43,233 | 0 | 0 | 0 | For |
| Fidelity | 37,721 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 23,084 | 0 | 0 | 0 | For |
| Charles Schwab | 9,534 | 0 | 0 | 0 | For |
| SEI | 7,300 | 0 | 0 | 0 | For |
| Global X | 6,840 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,767 | 0 | 0 | 0 | For |
| Calvert | 5,678 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 5,135 | 0 | 0 | 0 | For |
| Principal | 4,557 | 0 | 0 | 0 | For |
| ProShares | 3,636 | 0 | 0 | 0 | For |
| Goldman Sachs | 2,752 | 0 | 0 | 0 | For |
| Nationwide | 2,553 | 0 | 0 | 0 | For |
| State Street | 2,430 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 1,600 | 0 | 0 | 0 | For |
| TIAA | 1,564 | 0 | 0 | 0 | For |
| Morgan Stanley | 1,563 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 1,300 | 0 | 0 | 0 | For |
| Voya | 806 | 0 | 0 | 0 | For |
| John Hancock | 589 | 0 | 0 | 0 | For |
| Guggenheim | 565 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. All 32 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 68,369,896 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | FRANKLIN STRATEGIC SERIES | 0.64% |
| 2 | Vanguard | 0.16% |
| 3 | BlackRock | 0.13% |
| 4 | Lincoln Financial | 0.06% |
| 5 | Equitable | 0.06% |
| 6 | Fidelity | 0.06% |
| 7 | Bridge Builder Trust | 0.03% |
| 8 | Charles Schwab | 0.01% |
| 9 | SEI | 0.01% |
| 10 | Global X | 0.01% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Laurion Capital Management LP | 3.84% |
| 2 | PFIZER INC | 3.53% |
| 3 | ACORN CAPITAL ADVISORS, LLC | 1.55% |
| 4 | BLAIR WILLIAM & CO/IL | 1.05% |
| 5 | FRANKLIN ADVISERS INC | 0.95% |
| 6 | Putnam | 0.64% |
| 7 | State Street | 0.59% |
| 8 | BlackRock | 0.47% |
| 9 | Northern Trust | 0.37% |
| 10 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0.20% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| BlackRock | 3,981,387 | 5.82% | Form 13F, quarter ended March 31, 2026 |
| Vanguard Group | 3,722,085 | 5.44% | Form 13F, quarter ended March 31, 2026 |
| Gary W. Pace, Ph.D. | 2,231,200 | 3.26% | Proxy statement (DEF 14A), table as of August 26, 2026 |
| Mark Erlander, Ph.D. | 2,103,930 | 3.08% | Proxy statement (DEF 14A), table as of August 26, 2026 |
| Geode Capital | 1,599,663 | 2.34% | Form 13F, quarter ended March 31, 2026 |
| Franklin Templeton | 1,205,803 | 1.76% | Form 13F, quarter ended March 31, 2026 |
| State Street | 1,186,947 | 1.74% | Form 13F, quarter ended March 31, 2026 |
| James Levine | 961,495 | 1.41% | Proxy statement (DEF 14A), table as of August 26, 2026 |
| Northern Trust | 493,205 | 0.72% | Form 13F, quarter ended March 31, 2026 |
| Mani Mohindru, Ph.D. | 427,834 | 0.63% | Proxy statement (DEF 14A), table as of August 26, 2026 |
Percentages above are of 68,369,896 shares outstanding, as reported by Cardiff Oncology, Inc. on its Form 10-Q dated April 30, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At Cardiff Oncology, Inc.'s shareholder meeting held June 11, 2026, in the 2025-2026 proxy season, 109 asset managers reported votes on at least one of its 9 ballot items in their SEC Form N-PX filings, covering 926 separate fund positions. On the most widely held item on that ballot — Proposal to approve, on an advisory basis, the compensation of the Company's named executive… — Cardiff Oncology, Inc.'s filing reports the proposal as approved, with 91% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Cardiff Oncology, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 11, 2026.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Cardiff Oncology, Inc.’s 10-Q dated April 30, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
Cardiff Oncology, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Proxy Votes Now, “Cardiff Oncology (CRDF) 2026 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/cardiff-oncology-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.